切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2019, Vol. 15 ›› Issue (05) : 571 -578. doi: 10.3877/cma.j.issn.1673-5250.2019.05.015

所属专题: 文献

论著

卵巢交界性浆黏液性肿瘤临床病理学分析及文献复习
贾静1,(), 石新兰1, 李玉广1, 李振强1, 孙磊2   
  1. 1. 首都医科大学石景山教学医院/北京市石景山医院病理科 100043
    2. 首都医科大学附属北京地坛医院病理科 100015
  • 收稿日期:2019-07-07 修回日期:2019-09-16 出版日期:2019-10-01
  • 通信作者: 贾静

Ovarian seromucinous borderline tumors: a clinicopathological analysis and literature review

Jing Jia1,(), Xinlan Shi1, Yuguang Li1, Zhenqiang Li1, Lei Sun2   

  1. 1. Department of Pathology, Shijingshan Teaching Hospital of Capital Medical University, Beijing Shijingshan Hospital, Beijing 100043, China
    2. Department of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
  • Received:2019-07-07 Revised:2019-09-16 Published:2019-10-01
  • Corresponding author: Jing Jia
  • About author:
    Corresponding author: Jia Jing, Email:
  • Supported by:
    Project of Major Supported Specialized Subject Construction of Medical Science in Shijingshan District, Beijing(20170008); " Qingmiao" Special Funding Project of Beijing Hospitals Authority(QML20181805)
引用本文:

贾静, 石新兰, 李玉广, 李振强, 孙磊. 卵巢交界性浆黏液性肿瘤临床病理学分析及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(05): 571-578.

Jing Jia, Xinlan Shi, Yuguang Li, Zhenqiang Li, Lei Sun. Ovarian seromucinous borderline tumors: a clinicopathological analysis and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2019, 15(05): 571-578.

目的

探讨卵巢交界性浆黏液性肿瘤(OSMBT)的临床病理学特征、诊断和鉴别诊断,并进行文献复习。

方法

选择2005—2017年,于北京市石景山医院进行手术治疗的4例OSMBT患者(患者1~4)为研究对象。采用回顾性分析方法,收集这4例患者的临床病例资料,对其临床病理学特征、诊断要点进行分析。本研究对OSMBT相关文献进行复习,设定文献检索策略为:以"卵巢肿瘤""浆黏液性肿瘤""交界性肿瘤""ovarian neoplasm""seromucinous neoplasm"及"borderline neoplasm"为关键词,在万方数据知识服务平台、中国知网数据库及PubMed数据库中,检索OSMBT相关文献,检索时间设定为2010年1月1日至2019年1月31日。总结OSMBT的临床病理学特点、诊断要点。本研究遵循的程序符合2013年修订的《世界医学协会赫尔辛基宣言》要求。

结果

①4例OSMBT患者的一般临床资料:发病年龄为29~65岁,中位年龄为40岁;主要临床表现为腹痛和盆腔包块;国际妇产科联盟(FIGO)分期均为Ⅰ期。手术方式:对患者1、2进行卵巢囊肿剔除术,患者3、4进行全子宫及双侧附件切除术。手术切除标本的大体观察:肿瘤直径为0.9~10.0 cm,平均为4.4 cm;患者2肿瘤发生于双侧卵巢;患者1~3肿瘤呈单房囊性(囊壁内可见乳头状结构),患者4肿瘤呈实性。手术切除标本的活组织病理学检查结果:肿瘤囊壁衬覆分支乳头状结构,无间质浸润。肿瘤上皮细胞内、乳头状结构的间质内和肿瘤性腺体的腺腔内,均可见明显中性粒细胞浸润。乳头被覆上皮细胞复层排列,主要由宫颈管型黏液性上皮、浆液性上皮、嗜酸性细胞组成。细胞核呈轻、中度异型性,核分裂象少见。患者2伴发子宫内膜异位症。手术切除标本的免疫组化结果:免疫表型CK7、PAX8呈阳性,CK20、CDX2呈阴性。随访结果:对4例患者于术后随访15~156个月,平均为78.8个月,均未发现OSMBT复发或转移。②文献复习结果:共计筛选出9篇OSMBT相关文献,涉及OSMBT患者为86例。其主要临床表现为腹胀、腹痛、下腹不适等,中位年龄为49岁;肿瘤平均直径为7.9 cm;19.1%(13/68)患者肿瘤发生于双侧卵巢;34.9%(30/86)患者伴有子宫内膜异位症;91.2%(62/68)患者FIGO分期为Ⅰ期。8篇文献报道对66例患者的平均随访时间为35.9个月,OSMBT复发率为6.1%(4/66)。

结论

OSMBT临床较少见,多见于较年轻女性,其发生主要与子宫内膜异位症相关。临床对该病的诊断主要根据手术切除标本的活组织病理学检查和免疫组化检测结果,需注意与卵巢交界性浆液性、黏液性肿瘤及癌的鉴别诊断。OSMBT患者多为FIGO Ⅰ期,预后良好。对于需保留生育功能的年轻OSMBT患者,可采取卵巢囊肿剔除术治疗,并且术后需密切随访。

Objective

To investigate the clinicopathological characteristics, diagnosis and differential diagnosis of ovarian seromucinousborderline tumors (OSMBT), and review the related literature.

Methods

From 2005 to 2017, a total of 4 patients with OSMBT who underwent surgery at Beijing Shijingshan Hospital were selected as research subjects. The clinical data of the patients were collected by retrospective analysis method and the clinicopathological features, diagnosis of the patients were summarized. With the following keywords of " ovarian neoplasm" " seromucinous neoplasm" and " borderline neoplasm" both in Chinese and English, literature related to OSMBT were searched from Wanfang Data Knowledge Service Platform, China National Knowledge Infrastructure database and PubMed database, and literature retrieval time was set from January 1 of 2010 to January 31 of 2019. Clinicopathological features and diagnosis of OSMBT in searched literature were summarized. This study was in line with the requirement of World Medical Association of Helsinki revised in 2013.

Results

①The results of 4 patients with OSMBT in this study were as follows. General clinical data: the patients′ age were from 29 to 65 years old, with a median age of 40 years old. The major clinical manifestations included abdominal pain and masses in pelvic cavity. The stages of International Federation of Gynecology and Obstetrics (FIGO) of 4 patients all were stage Ⅰ. Surgical methods: patient 1 and 2 underwent ovarian cystectomy, and patient 3 and 4 underwent hysterectomy and bilateral salpingo-oophorectomy. Appearance observation of surgically removed specimens: the tumors of 4 patients ranged in diameter from 0.9-10.0 cm, and the average diameter of these tumors was 4.4 cm. Patient 2 was bilateral OSMBT. The masses of tumors were described as unilocular cyst with papillary architecture in patient 1 to 3, and as solid in patient 4. Histopathological results of surgically removed specimens: the OSMBT tissues showed complex branched papillary architecture, without stromal invasion. Significant neutrophil infiltration was observed in the tumor epithelium, stroma of papillary architecture and glandular lumen of tumor gland. The lining epithelium was stratified and composed mostly of endocervical-type mucous, serous epithelium and hobnail cells with eosinophilic cytoplasm, and the nuclei were mild and moderately heterogeneous, and karyokinesis was rare. Patient 2 with bilateral OSMBT was combined with endometriosis. Immunohistochemisty results of surgically removed specimens: the immunophenotype of these tumor tissues exhibited CK7+ /PAX8+ /CK20-/CDX2-. Follow-up results: none OSMBT recurrence or metastasis was found in 15 to 156 months (average of 78.8 months) follow-up of all the 4 patients. ②The results of literature review were as follows. A total of 9 literature related with OSMBT were retrieved, involving 86 cases of OSMBT patients. The main clinical manifestations of them were abdominal distension, abdominal pain, abdominal discomfort, and so on. The median age of them was 49 years old. The average diameter of these tumors was 7.9 cm. Among them, 13 cases (19.1%, 13/68) were bilateral OSMBT, 30 cases (34.9%, 30/86) were accompanied with endometriosis, and 62 cases (91.2%, 62/86) were FIGO Ⅰstage. The average follow-up time was 35.9 months among 66 patients in 8 pieces of literature and the recurrence rate of OSMBT was 6.1% (4/66).

Conclusions

OSMBT is a kind of rare ovarian neoplasm and mainly associated with endometriosis. Most OSMBT patients are young. Histopathological detection results as well as immunohistochemical marker may help in pathologic diagnosis of OSMBT. Attention should be paid to the differential diagnosis from ovarian borderline serous, mucinous tumor and carcinoma before final diagnosis. Most patients with OSMBT are FIGO Ⅰ stage and have a good prognosis. Unilateral oophorectomy and follow-up closely could be a valid proposal in young patients who wish to preserve their fertility.

表1 本组4例OSMBT患者的一般临床资料
表2 本组4例OSMBT患者手术切除标本的大体观察结果
图4 患者1(29岁)手术切除标本的活组织病理学检查,可见肿瘤上皮细胞核呈轻、中度异型性,核分裂象少见(HE染色,×200)
表3 文献复习检索的9篇文献共计报道86例OSMBT患者的临床病例资料
[1]
Kurman RJ, Carcangiu ML, Herrington S, et al. WHO classification of tumours of female reproductive organs [M]. 4th ed. Lyon: IARC, 2014: 38-40.
[2]
宋光耀,王亚萍,李广慧,等. 卵巢交界性浆黏液性肿瘤的临床病理学特征[J]. 中国医师进修杂志,2019, 42(1): 10-13.
[3]
董燕燕,刘云霄,屈重霄. 卵巢交界性浆黏液性肿瘤临床病理特征分析[J]. 肿瘤研究与临床,2018, 30(9): 603-606.
[4]
孙力,宋艳,李宁,等. 黏液性卵巢交界性肿瘤的临床病理特征及复发危险因素[J]. 中华肿瘤杂志,2017, 39(8): 589-594.
[5]
陈友权,魏清,张玉荣,等. 卵巢交界性肿瘤12例临床病理分析[J]. 中国现代医生,2018, 56(23): 133-136.
[6]
Newton CL, Brockbank E, Singh N, et al. A case of stage 4B seromucinous ovarian borderline tumor with endometriosis and review of the literature[J]. Int J Gynecol Pathol, 2017, 36(2): 195-199.
[7]
Kurata Y, Kido A, Moribata Y, et al. Differentiation of seromucinous borderline tumor from serous borderline tumor on MR imaging[J]. Magn Reson Med Sci, 2018, 17(3): 211-217.
[8]
Nakamura E, Sato Y, Moriguchi S, et al. Ovarian seromucinous borderline tumor and clear cell carcinoma: an unusual combination[J]. Case Rep Obstet Gynecol, 2015, 2015: 690891.
[9]
Karpathiou G, Chauleur C, Corsini T, et al. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors[J]. Ann Diagn Pathol, 2017, 27: 28-33.
[10]
D′Angelo E, Dadmanesh F, Pecorelli S, et al. Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (müllerian) type[J]. Int J Gynecol Pathol, 2010, 29(6): 529-532.
[11]
Fox H, Langley FA. Tumors of the Ovary[M]. Chicago: William Heinemann, 1976: 252.
[12]
Rutgers JL, Scully RE. Ovarian Mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis[J]. Cancer, 1988, 61(2): 340-348.
[13]
Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy. A clinicopathologic analysis[J]. Cancer, 1988, 61(3): 546-554.
[14]
Shappell HW, Riopel MA, Smith Sehdev AE, et al. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas[J]. Am J Surg Pathol, 2002, 26(12): 1529-1541.
[15]
Tavassoli FA, Devilee P. 乳腺及女性生殖器官肿瘤病理学和遗传学[M].程虹,译. 北京:人民卫生出版社,2006: 171-176.
[16]
Kurman RJ, Shih IM. Seromucinous tumors of the ovary. What′s in a name?[J]. Int J Gynecol Pathol, 2016, 35(1): 78-81.
[17]
郑文新,沈丹华,郭东辉. 妇产科病理学[M]. 北京:科学出版社,2013: 587-588.
[18]
倪皓,周晓军. 免疫组化在卵巢交界性肿瘤诊断和鉴别诊断中的研究进展[J].诊断病理学杂志,2016, 23(6): 462-465.
[19]
Chene G, Ouellet V, Rahimi K, et al. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis[J]. Int J Gynaecol Obstet, 2015, 130(1): 27-30.
[20]
Kim KR, Choi J, Hwang JE, et al. Endocervical-like (Müllerian) mucinous borderline tumors of the ovary are frequently associated with the KRAS mutation[J]. Histopathology, 2010, 57(4): 587-596.
[21]
Matias-Guiu X, Stewart CJR. Endometriosis-associated ovarian neoplasia[J]. Pathology, 2018, 50(2): 190-204.
[22]
Taylor J, McCluggage WG. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm[J]. Am JSurgPathol, 2015, 39(7): 983-992.
[23]
唐绍娴,孙艺华,许燕. 卵巢浆黏液性癌临床病理学分析[J].中华病理学杂志,2016, 45(11): 774-779.
[1] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[2] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[3] 罗丹, 孔为民, 陈姝宁, 赵小玲, 谢云凯. 子宫内膜异位症患者在位及异位内膜上皮细胞-间充质转化相关生物标志物的变化[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 530-539.
[4] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[5] 周东杰, 蒋敏, 范海瑞, 高玲玲, 孔祥, 卢丹, 王丽萍. 非编码RNA在卵泡发育成熟中作用及其机制的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 387-393.
[6] 陈荟竹, 郭应坤, 汪昕蓉, 宁刚, 陈锡建. 上皮性卵巢癌"二元论模型"的分子生物学研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 394-402.
[7] 韩春颖, 王婷婷, 李艳艳, 朴金霞. 子宫内膜癌患者淋巴管间隙浸润预测因素研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 403-409.
[8] 刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[9] 魏权, 张燊, 陈慧佳, 邹姮, 胡丽娜. 女性生殖道微生物群与辅助生殖技术相关性研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 151-155.
[10] 刘艳艳, 谭曦, 彭雪. 妊娠合并膀胱低度恶性潜能乳头状尿路上皮肿瘤并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 212-218.
[11] 张明, 王骥, 赵文星. 保留胰腺功能的限制性胰腺切除术在良性及交界性肿瘤中临床应用研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 562-565.
[12] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
[13] 刘育昕, 王子晗, 张艺馨, 栾永婕, 孟凯. 肾母细胞瘤基因1在卵巢疾病发病机制中的研究进展[J]. 中华诊断学电子杂志, 2023, 11(03): 178-183.
[14] 贾岩龙, 李锋, 武峰, 钟梓杰, 聂婷婷, 罗家滨, 罗锐. 钙化性腱膜纤维瘤的影像学特征[J]. 中华诊断学电子杂志, 2023, 11(01): 42-48.
[15] 王可珺, 李吉镇, 马标, 续慧超, 谌红珊, 刘雷. 肌酐/胱抑素C对晚期上皮性卵巢癌术后并发症的预测价值[J]. 中华诊断学电子杂志, 2023, 11(01): 49-55.
阅读次数
全文


摘要